Titus B. Ball - 02 Sep 2025 Form 4 Insider Report for BeOne Medicines Ltd. (ONC)

Role: Principal Accounting Officer
Signature: /s/ Qing Nian, as Attorney-in-Fact
Issuer symbol: ONC
Transactions as of: 02 Sep 2025
Net transactions value: -$39,865
Form type: 4
Filing time: 04 Sep 2025, 17:29:56 UTC
Previous filing: 12 Jun 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Ball Titus B.	Principal Accounting Officer	C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, SWITZERLAND	/s/ Qing Nian, as Attorney-in-Fact	04 Sep 2025	0001675628

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ONC	American Depositary Shares	Sale	$39,865	-122	-100%	$326.76	0	02 Sep 2025	Direct	F1, F2
holding	ONC	Ordinary Shares						72,397	02 Sep 2025	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each American Depositary Share represents 13 Ordinary Shares.
F2	The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of August 31, 2023, subject to continued service.